Related Experiment Video

Updated: Aug 6, 2026

A Semi-High-Throughput Adaptation of the NADH-Coupled ATPase Assay for Screening Small Molecule Inhibitors
10:28

A Semi-High-Throughput Adaptation of the NADH-Coupled ATPase Assay for Screening Small Molecule Inhibitors

Published on: August 17, 2019

Metabolism of ATP-binding cassette drug transporter inhibitors: complicating factor for multidrug resistance

Nicole H P Cnubben1, Heleen M Wortelboer, Jelmer J van Zanden

  • 1TNO Quality of Life, PO Box 360, 3700 AJ Zeist, The Netherlands. Cnubben@pharma.tno.nl

Expert Opinion on Drug Metabolism & Toxicology
|August 23, 2006
PubMed

Insights

Inhibitors targeting ATP-binding cassette (ABC) proteins can combat cancer drug resistance by blocking cellular defense mechanisms. Understanding inhibitor metabolism is crucial for effective cancer treatment strategies.

Area of Science:

  • Biochemistry
  • Pharmacology
  • Molecular Biology

Background:

  • ATP-binding cassette (ABC) proteins are crucial for cellular defense against toxins, including anticancer drugs.
  • This defense mechanism contributes to multidrug resistance (MDR), diminishing the efficacy of cancer therapies.
  • Inhibitors of ABC transporters offer a strategy to overcome drug resistance and improve cancer treatment outcomes.

Purpose of the Study:

  • To review various inhibitors targeting multidrug resistance-related ABC proteins.
  • To highlight the implications of inhibitor metabolism on drug transport and resistance reversal.
  • To explore the potential of natural compounds as ABC transporter inhibitors.

Main Methods:

  • Literature review of existing research on ABC transporter inhibitors.
  • Analysis of recent data on the metabolism of natural compound inhibitors.
  • Discussion of the impact of metabolism on drug transport and therapeutic potential.

Main Results:

  • Various classes of inhibitors for MDR-related ABC proteins have been identified.
  • Metabolism of inhibitors, particularly natural compounds, significantly influences their efficacy.
  • Metabolic pathways can affect how effectively inhibitors reverse drug transport and overcome resistance.

Conclusions:

  • Inhibitors of ABC transporters are promising for reversing drug resistance in cancer.
  • The metabolism of these inhibitors is a critical factor influencing their therapeutic application.
  • Further research into inhibitor metabolism is essential for developing effective treatments for drug-resistant cancers.

More Related Videos

Expression, Detergent Solubilization, and Purification of a Membrane Transporter, the MexB Multidrug Resistance Protein10:43

Expression, Detergent Solubilization, and Purification of a Membrane Transporter, the MexB Multidrug Resistance Protein

Published on: December 3, 2010

Characterizing Multidrug Efflux Systems in Acinetobacter baumannii Using an Efflux-Deficient Bacterial Strain and a Single-Copy Gene Expression System05:06

Characterizing Multidrug Efflux Systems in Acinetobacter baumannii Using an Efflux-Deficient Bacterial Strain and a Single-Copy Gene Expression System

Published on: January 5, 2024

Related Concept Videos

Carrier-Mediated Transport01:06

Carrier-Mediated Transport

Carrier-mediated transport is a pivotal process in drug absorption, particularly for lipid-insoluble drugs, and encompasses facilitated diffusion and active transport. Facilitated diffusion allows drugs to move along their concentration gradient without energy expenditure, while active transport utilizes ATP to drive drug movement against this gradient.
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
ABC Transporters: Importer01:27

ABC Transporters: Importer

ATP-binding cassette or ABC transporters are a class of ATP-driven pumps that hydrolyze ATP to move solutes across the membrane. They can be grouped into importers and exporters. While exporters are present in all domains of life, importers exist only in bacteria and some plants.
In bacteria, based on the number of transmembrane helices and the chemical nature of their substrates, the ABC importers can be divided into three types:
Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters01:16

Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters

The pharmacogenetics of drug transporters is increasingly recognized as a critical factor influencing interindividual variability in drug absorption, distribution, and elimination. These membrane-bound proteins regulate drugs' movement across cellular barriers by actively pumping them out (efflux) or facilitating their uptake (influx). Among the major transporter families, ATP-binding cassette (ABC) and solute carrier (SLC) transporters play particularly prominent roles. Genetic polymorphisms...
ABC Transporters: Exporter01:31

ABC Transporters: Exporter

ATP-binding cassette or ABC transporter is the largest superfamily of integral membrane proteins. The transporters have transmembrane-binding domains (TMDs) and nucleotide-binding domains (NBDs). The TMDs are specific to their substrates, whereas the NBDs are similar to engines that complete ATP hydrolysis to complete the substrate transport. They can be full transporters consisting of two TMDs and NBDs, half transporters with one TMD and NBD, while some encoded with a single TMD or NBD are...
Drug Elimination by Renal Route: Tubular Secretion01:15

Drug Elimination by Renal Route: Tubular Secretion

Once the process of glomerular filtration is completed, blood carrying unfiltered drug molecules traverses through efferent arterioles and makes its way into the peritubular capillaries in the proximal tubule. A variety of carriers play a pivotal role in actively secreting drugs from these peritubular capillaries into the tubular fluid. The organic anion transporter transfers acidic drugs, against an electrochemical gradient, from the peritubular capillaries into the renal tubule cells and...
Pharmacokinetics: Drug–Drug Interactions01:25

Pharmacokinetics: Drug–Drug Interactions

Drug interactions occur when the pharmacological effect of one drug is altered by another substance, either enhancing or diminishing its activity. The drug whose activity is altered is known as the object drug, and the substance causing the alteration is called the agent drug or the precipitant. The net effects of these interactions are mostly undesirable, leading to decreased effectiveness or increased adverse effects. In rare cases, interactions can be beneficial, such as the enhanced...